{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:34:38Z","timestamp":1787016878263,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04394-w","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:52:08Z","timestamp":1781013128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting sublingual immunotherapy efficacy in allergic rhinitis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiayue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"4394_CR1","doi-asserted-by":"publisher","unstructured":"Kanayama M, Lu C, Luo J, et al. AR Splicing Variants and Resistance to AR Targeting Agents. Cancers (Basel). 2021;13(11). https:\/\/doi.org\/10.3390\/cancers13112563.","DOI":"10.3390\/cancers13112563"},{"key":"4394_CR2","doi-asserted-by":"publisher","first-page":"1274241","DOI":"10.3389\/fimmu.2023.1274241","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, Lei S. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis. Front Immunol. 2023;14:1274241. https:\/\/doi.org\/10.3389\/fimmu.2023.1274241.","journal-title":"Front Immunol"},{"key":"4394_CR3","doi-asserted-by":"publisher","first-page":"101136DOI","DOI":"10.1016\/j.lanepe.2024.101136","volume":"48","author":"A Schuster","year":"2025","unstructured":"Schuster A, Caimmi D, Nolte H, et al. Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis\/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial. Lancet Reg Health Eur. 2025;48:101136DOI. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101136.","journal-title":"Lancet Reg Health Eur"},{"key":"4394_CR4","doi-asserted-by":"publisher","first-page":"1454333","DOI":"10.3389\/fcimb.2024.1454333","volume":"14","author":"J Wu","year":"2024","unstructured":"Wu J, Wang D, He WJ, et al. Allergen-specific sublingual immunotherapy altered gut microbiota in patients with allergic rhinitis. Front Cell Infect Microbiol. 2024;14:1454333. https:\/\/doi.org\/10.3389\/fcimb.2024.1454333.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4394_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.18502\/ijaai.v23i1.14953","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Xiao H, Zeng Y, et al. Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis. Iran J Allergy Asthma Immunol. 2024;23(1):52\u20138. https:\/\/doi.org\/10.18502\/ijaai.v23i1.14953.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"6","key":"4394_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/19458924241269786","volume":"38","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Jiang H, Long Y, et al. The Evaluation Value of the Modified Lund-Kennedy Nasal Endoscopy Score on the Efficacy of Sublingual Immunotherapy for Allergic Rhinitis. Am J Rhinol Allergy. 2024;38(6):366\u201372. https:\/\/doi.org\/10.1177\/19458924241269786.","journal-title":"Am J Rhinol Allergy"},{"key":"4394_CR7","doi-asserted-by":"publisher","unstructured":"Liu W, Zeng Q, Luo R. Predictors for Short-Term Efficacy of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis. Mediators Inflamm. 2020;2020(1847061). https:\/\/doi.org\/10.1155\/2020\/1847061.","DOI":"10.1155\/2020\/1847061"},{"issue":"5","key":"4394_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jaci.2009.02.012","volume":"123","author":"G Di Lorenzo","year":"2009","unstructured":"Di Lorenzo G, Mansueto P, Pacor ML, et al. Evaluation of serum s-IgE\/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. J Allergy Clin Immunol. 2009;123(5):1103\u201310. https:\/\/doi.org\/10.1016\/j.jaci.2009.02.012.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4394_CR9","doi-asserted-by":"publisher","first-page":"e12916","DOI":"10.1002\/kjm2.12916","volume":"41","author":"TT Wei","year":"2025","unstructured":"Wei TT, Gao K, Tai JH, et al. A study of specific immunoglobulin G4 expression in allergic rhinitis and its value in assessing efficacy and in predicting prognosis of sublingual immunotherapy. Kaohsiung J Med Sci. 2025;41(1):e12916. https:\/\/doi.org\/10.1002\/kjm2.12916.","journal-title":"Kaohsiung J Med Sci"},{"issue":"4","key":"4394_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.13201\/j.issn.1001-1781.2019.04.011","volume":"33","author":"ZH Sun","year":"2019","unstructured":"Sun ZH, Gao ZH, Xue JM, et al. [The efficacy of sublingual immunotherapy for allergic rhinitis and the predictive role of cytokines in its therapeutic effect]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019;33(4):332\u20136. https:\/\/doi.org\/10.13201\/j.issn.1001-1781.2019.04.011.","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"issue":"4","key":"4394_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/alr.23090","volume":"13","author":"SK Wise","year":"2023","unstructured":"Wise SK, Damask C, Roland LT, et al. International consensus statement on allergy and rhinology: Allergic rhinitis\u2009\u2013\u20092023. Int Forum Allergy Rhinol. 2023;13(4):293\u2013859. https:\/\/doi.org\/10.1002\/alr.23090.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"5suppl","key":"4394_CR12","doi-asserted-by":"publisher","first-page":"s505","DOI":"10.1177\/0145561319882593","volume":"100","author":"JH Jung","year":"2021","unstructured":"Jung JH, Kang TK, Kang IG, et al. Comparison of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites in Korea. Ear Nose Throat J. 2021;100(5suppl):s505\u201312. https:\/\/doi.org\/10.1177\/0145561319882593.","journal-title":"Ear Nose Throat J"},{"issue":"8","key":"4394_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/14712598.2025.2531035","volume":"25","author":"MA Tosca","year":"2025","unstructured":"Tosca MA, Ferrecchi C, D\u2019ambrosio T, et al. Predicting and overcoming poor patient responses to sublingual immunotherapy for allergic diseases. Expert Opin Biol Ther. 2025;25(8):821\u201333. https:\/\/doi.org\/10.1080\/14712598.2025.2531035.","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"4394_CR14","first-page":"35","volume":"24","author":"G Ciprandi","year":"2014","unstructured":"Ciprandi G, Silvestri M. Serum specific IgE: a biomarker of response to allergen immunotherapy. J Investig Allergol Clin Immunol. 2014;24(1):35\u20139.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"4394_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40521-018-0176-2","volume":"5","author":"M Penagos","year":"2018","unstructured":"Penagos M, Eifan AO, Durham SR, et al. Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis. Curr Treat Options Allergy. 2018;5(3):275\u201390. https:\/\/doi.org\/10.1007\/s40521-018-0176-2.","journal-title":"Curr Treat Options Allergy"},{"issue":"6","key":"4394_CR16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","volume":"140","author":"MH Shamji","year":"2017","unstructured":"Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol. 2017;140(6):1485\u201398. https:\/\/doi.org\/10.1016\/j.jaci.2017.10.010.","journal-title":"J Allergy Clin Immunol"},{"issue":"3\u20134","key":"4394_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000452333","volume":"171","author":"S Qi","year":"2016","unstructured":"Qi S, Chen H, Huang N, et al. Early Intervention Improves Clinical Responses to House Dust Mite Immunotherapy in Allergic Rhinitis Patients. Int Arch Allergy Immunol. 2016;171(3\u20134):234\u201340. https:\/\/doi.org\/10.1159\/000452333.","journal-title":"Int Arch Allergy Immunol"},{"key":"4394_CR18","doi-asserted-by":"publisher","unstructured":"Jurkiewicz K, Jutel M, Smolinska S. Update on HDM Allergy: Principal Changes over the Years. Int J Mol Sci. 2025;26(12). https:\/\/doi.org\/10.3390\/ijms26125660.","DOI":"10.3390\/ijms26125660"},{"issue":"1","key":"4394_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.clim.2010.12.022","volume":"139","author":"T Fujimura","year":"2011","unstructured":"Fujimura T, Yonekura S, Horiguchi S, et al. Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. Clin Immunol. 2011;139(1):65\u201374. https:\/\/doi.org\/10.1016\/j.clim.2010.12.022.","journal-title":"Clin Immunol"},{"issue":"5","key":"4394_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000528969","volume":"184","author":"R Zhang","year":"2023","unstructured":"Zhang R, Zhang L, Li P, et al. Epithelial Barrier in the Nasal Mucosa, Related Risk Factors and Diseases. Int Arch Allergy Immunol. 2023;184(5):481\u2013501. https:\/\/doi.org\/10.1159\/000528969.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"4394_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4193\/Rhino15.223","volume":"54","author":"D Sakurai","year":"2016","unstructured":"Sakurai D, Yonekura S, Iinuma T, et al. Sublingual immunotherapy for allergic rhinitis: subjective versus objective tools to evaluate its success. Rhinology. 2016;54(3):221\u201330. https:\/\/doi.org\/10.4193\/Rhino15.223.","journal-title":"Rhinology"},{"key":"4394_CR22","doi-asserted-by":"publisher","first-page":"405813","DOI":"10.5402\/2011\/405813","volume":"2011","author":"G Zhang","year":"2011","unstructured":"Zhang G, Hayden CM, Goldblatt J, et al. Th2 Cytokine Levels Distort the Association of IL-10 and IFN-\u03b3 with Allergic Phenotypes. ISRN Allergy. 2011;2011:405813. https:\/\/doi.org\/10.5402\/2011\/405813.","journal-title":"ISRN Allergy"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04394-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:25:51Z","timestamp":1787012751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04394-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4394"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04394-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Committees for the Ethical Review of Research involving Human Subjects from Shandong Provincial Hospital Affiliated to Shandong First Medical University (Approval No. SDPH-2024-047). Written informed consent was obtained from all adult participants. For participants under the age of 16, written informed consent was obtained from their parents or legal guardians. This study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"358"}}